Feasibility of adjuvant chemotherapy with S-1 consisting of a 4-week administration and a two-week rest period in patients with completely resected non-small cell lung cancer

Author： Okumura  

Publisher： Spandidos Publications

ISSN： 2049-9469

Source： Molecular and Clinical Oncology, Vol.1, Iss.1, 2013-01, pp. : 124-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small RNAs and Non-Small Cell Lung Cancer

By  

Current Molecular Medicine, Vol. 6, Iss. 3, 2006-05 ,pp. : 339-349

Bentham Science Publishers

Access to resources Recommend Favorite

Pemetrexed versus vinorelbine treatment of advanced nonsquamous non-small cell lung cancer in elderly patients

By Chen  

Molecular and Clinical Oncology, Vol. 1, Iss. 3, 2013-01 ,pp. : 553-557

Spandidos Publications

Access to resources Recommend Favorite

Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer

By Ulivi Paola   Silvestrini Rosella  

Cellular Oncology, Vol. 36, Iss. 6, 2013-12 ,pp. : 439-448

Springer Publishing Company

Access to resources Recommend Favorite

Association of EGFR mutations with low BRCA1 gene expression in non-small cell lung cancer

By Li   Xie   Lai  

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 195-199

Spandidos Publications

Access to resources Recommend Favorite

A phase II study of S1 in relapsed small cell lung cancer

By Kudo   Ohyanagi   Horiike   Miyauchi   Tahanaka   Yanagitani   Saito   Kaburaki   Sakatani   Horai   Nishio  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 263-266

Spandidos Publications

Access to resources Recommend Favorite